# FDA Inspection 1070434 - GBA Pharma GmbH - October 12, 2018

Source: https://www.keypedia.com/records/fda_inspections/gba-pharma-gmbh/30ffd245-ccb0-457d-95fe-52465980c28e
Source feed: FDA_Inspections

> FDA Inspection 1070434 for GBA Pharma GmbH on October 12, 2018. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1070434
- Company Name: GBA Pharma GmbH
- Inspection Date: 2018-10-12
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1261571 - 2024-12-11](https://www.keypedia.com/records/fda_inspections/gba-pharma-gmbh/5aead7de-0b54-4145-a0a2-1ff609282fa9)
- [FDA Inspection 1261571 - 2024-12-11](https://www.keypedia.com/records/fda_inspections/gba-pharma-gmbh/751a5f9b-9de0-4e58-bf04-1e83e7aaae9c)
- [FDA Inspection 1261571 - 2024-12-11](https://www.keypedia.com/records/fda_inspections/gba-pharma-gmbh/318881b7-6823-4eac-8628-d1a963a63405)
- [FDA Inspection 1261571 - 2024-12-11](https://www.keypedia.com/records/fda_inspections/gba-pharma-gmbh/79c5e286-5b6d-4d07-851e-1a3082e837ea)
- [FDA Inspection 865034 - 2013-10-18](https://www.keypedia.com/records/fda_inspections/gba-pharma-gmbh/0d2c79c2-414b-480f-85b4-702e7dd15250)

Company: https://www.keypedia.com/companies/gba-pharma-gmbh/9493ddfc-e675-4367-ac97-c959ddafdf46

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c